Anti-platelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: randomised controlled proof of concept trial (APPLE COPD-ICON 2)

Back

ESC Premium Access

Anti-platelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: randomised controlled proof of concept trial (APPLE COPD-ICON 2)

Session: Poster Session 1 - Atrial fibrillation, anti-platelet therapy, anticoagulation and bleeding

Topic: Cardiovascular Risk Assessment

Speaker: Professor V. Kunadian (Newcastle-Upon-Tyne, GB)

Event: ESC Congress 2019

Congress Presentation

About the speaker

Professor Vijay Kunadian

Newcastle University, Newcastle-Upon-Tyne (United Kingdom of Great Britain & Northern Ireland)

19 presentations

5 followers

12 more presentations in this session

Risk of major gastrointestinal bleed in relation to vascular disease risk in 0.5M UK Biobank participants

Speaker: Doctor I. Hammami (Oxford, GB)

Access

Abstract

Anticoagulation strategies based on warfarin or direct oral anticoagulants compared to major hemorrhagic events: the relevance of patients aged 75 years or older.

Speaker: Doctor A. Conti (Massa, IT)

Access

Abstract

Slides

CHA(2)DS(2)-VASc score calibration in anticoagulated vs non-anticoagulated patients in a healthcare area

Speaker: Doctor A. Baluja (Santiago de Compostela, ES)

Access

Abstract

Slides

The effect of hypertension and metabolic syndrome on left atrial function in patients with paroxysmal atrial fibrillation undergoing catheter ablation

Speaker: Doctor A. Katbeh (Aalst, BE)

Access

Abstract

Slides

Nocturnal hypoxemic burden in ambulatory patients with atrial fibrillation: a disease-orientated assessment of sleep-disordered breathing severity.

Speaker: Professor D. Linz (Maastricht, NL)

Access

Abstract

Access the full session

Poster Session 1 - Atrial fibrillation, anti-platelet therapy, anticoagulation and bleeding

Speakers: Professor V. Kunadian, Doctor I. Hammami, Doctor A. Conti, Doctor A. Baluja, Doctor A. Katbeh...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

Anti-platelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: randomised controlled proof of concept trial (APPLE COPD-ICON 2)

About the speaker

Professor Vijay Kunadian

12 more presentations in this session

Risk of major gastrointestinal bleed in relation to vascular disease risk in 0.5M UK Biobank participants

Anticoagulation strategies based on warfarin or direct oral anticoagulants compared to major hemorrhagic events: the relevance of patients aged 75 years or older.

CHA(2)DS(2)-VASc score calibration in anticoagulated vs non-anticoagulated patients in a healthcare area

The effect of hypertension and metabolic syndrome on left atrial function in patients with paroxysmal atrial fibrillation undergoing catheter ablation

Nocturnal hypoxemic burden in ambulatory patients with atrial fibrillation: a disease-orientated assessment of sleep-disordered breathing severity.

Access the full session

Poster Session 1 - Atrial fibrillation, anti-platelet therapy, anticoagulation and bleeding

About the event

ESC Congress 2019

ESC 365 is supported by